Result of General Meeting

23 September 2019

Inspiration Healthcare Group plc

("Inspiration Healthcare" or the "Company")

Result of General Meeting

Inspiration Healthcare Group plc (AIM:IHC), the global medical technology company, is pleased to announce that, at its General Meeting held at 14.00 p.m. today, all resolutions set out in the Circular dated 5 September 2019 were duly passed. Application has been made for 7,713,302 new ordinary shares of 10 pence each in the capital of the Company ("New Ordinary Shares") to be admitted to trading on AIM. It is expected that Admission and dealings in the 7,713,302 New Ordinary Shares will commence at 08:00 a.m. on 24 September 2019.

Following Admission, the Company's issued ordinary share capital will consist of 38,380,850 Ordinary Shares; no shares are held in treasury. The above figure of 38,380,850 Ordinary Shares may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the voting rights of the Company under the FCA's Disclosure Guidance and Transparency Rules.

A summary of the votes received will be made available on the Group's website at www.inspiration-healthcare.com. Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 5 September 2019.

Enquiries:

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies. 

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com